Penserra Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151K | Buy |
1,368
+1,266
| +1,241% | +$140K | ﹤0.01% | 676 |
|
|
2025
Q1 | $11K | Sell |
102
-3,156
| -97% | -$340K | ﹤0.01% | 889 |
|
|
2024
Q4 | $300K | Buy |
3,258
+3,156
| +3,094% | +$291K | 0.01% | 660 |
|
|
2024
Q3 | $8K | Hold |
102
| – | – | ﹤0.01% | 900 |
|
|
2024
Q2 | $7K | Hold |
102
| – | – | ﹤0.01% | 1036 |
|
|
2024
Q1 | $7K | Sell |
102
-5,665
| -98% | -$389K | ﹤0.01% | 965 |
|
|
2023
Q4 | $466K | Sell |
5,767
-1,210
| -17% | -$97.8K | 0.01% | 546 |
|
|
2023
Q3 | $522K | Sell |
6,977
-1,105
| -14% | -$82.7K | 0.01% | 494 |
|
|
2023
Q2 | $622K | Buy |
8,082
+7,647
| +1,758% | +$589K | 0.01% | 460 |
|
|
2023
Q1 | $35K | Sell |
435
-34,901
| -99% | -$2.81M | ﹤0.01% | 871 |
|
|
2022
Q4 | $3.03M | Buy |
+35,336
| New | +$3.03M | 0.07% | 270 |
|
|
2018
Q4 | – | Sell |
-4,600
| Closed | -$355K | – | 687 |
|
|
2018
Q3 | $355K | Buy |
4,600
+650
| +16% | +$50.2K | 0.02% | 357 |
|
|
2018
Q2 | $279K | Buy |
3,950
+150
| +4% | +$10.6K | 0.02% | 288 |
|
|
2018
Q1 | $286K | Buy |
3,800
+300
| +9% | +$22.6K | 0.03% | 230 |
|
|
2017
Q4 | $250K | Buy |
3,500
+550
| +19% | +$39.3K | 0.03% | 209 |
|
|
2017
Q3 | $246K | Buy |
2,950
+350
| +13% | +$29.2K | 0.06% | 170 |
|
|
2017
Q2 | $184K | Buy |
2,600
+944
| +57% | +$66.8K | 0.07% | 222 |
|
|
2017
Q1 | $112K | Buy |
1,656
+144
| +10% | +$9.74K | 0.01% | 289 |
|
|
2016
Q4 | $108K | Buy |
1,512
+216
| +17% | +$15.4K | 0.01% | 321 |
|
|
2016
Q3 | $102K | Buy |
1,296
+774
| +148% | +$60.9K | 0.01% | 275 |
|
|
2016
Q2 | $44K | Buy |
522
+174
| +50% | +$14.7K | 0.01% | 365 |
|
|
2016
Q1 | $31 | Buy |
348
+56
| +19% | +$5 | ﹤0.01% | 373 |
|
|
2015
Q4 | $29K | Buy |
+292
| New | +$29K | ﹤0.01% | 340 |
|